The findings from Florianópolis add an important dimension to ongoing debates about how antimicrobial resistance moves through food systems. While much of the global attention on resistant bacteria has focused on hospitals, livestock production, and terrestrial agriculture, coastal aquaculture occupies a distinctive position at the interface between human wastewater, environmental reservoirs, and direct food consumption. Oysters are particularly informative sentinels in this setting because their filter-feeding behavior concentrates particles and microorganisms from large volumes of seawater, effectively integrating the microbial signature of the surrounding environment over time. When that environment carries fecal contamination from urban runoff or inadequate sewage treatment, the bacteria it harbors, including strains carrying extended-spectrum β-lactamase genes and other resistance determinants, can be taken up and retained by the animals destined for human consumption.

The observation that identical sequence types and resistance profiles appeared at multiple points along the supply chain, from seawater through farmed oysters to commercially sold product, suggests that contamination is not randomly distributed but follows traceable routes of dissemination. This kind of genomic concordance is a powerful epidemiological signal. Whole genome sequencing allows researchers to distinguish between merely similar organisms and truly related clones, and when the same clone with the same resistance gene complement is recovered from water and from oysters offered to consumers, the most parsimonious explanation is that the water source seeded the product. It also implies that interventions targeting water quality at the farm level would have downstream benefits that extend all the way to the point of sale, whereas interventions applied only at later stages would leave the upstream reservoir intact.

The prominence of Escherichia coli and Klebsiella pneumoniae among the 167 resistant isolates deserves particular attention. Both species are members of the Enterobacterales order and are common inhabitants of the human and animal gut, which makes their presence in coastal waters a reliable indicator of fecal pollution. Klebsiella pneumoniae, in particular, is classified by the World Health Organization among the critical priority pathogens for which new treatments are urgently needed, largely because of its capacity to acquire and stack resistance genes, including carbapenemases in some lineages. Finding such organisms in an aquaculture environment intended for raw consumption underscores the stakes involved. The detection of extended-spectrum β-lactamase genes is especially concerning because these enzymes degrade penicillins and cephalosporins, the antibiotic classes most heavily used in both human medicine and, in some regions, animal husbandry. The additional identification of determinants conferring resistance to quinolones, aminoglycosides, tetracyclines, sulfonamides, and trimethoprim reflects the broader pattern seen in environmental Enterobacterales, where resistance rarely arrives as a single trait but instead arrives as a package of linked genes.

The plasmid association of many of these determinants is central to understanding why. Plasmids are mobile genetic elements that can replicate independently of the bacterial chromosome and transfer horizontally between strains and even between species. A resistance gene embedded on a broad-host-range plasmid can move from a relatively benign commensal organism into a more dangerous pathogen under the right selective conditions. Coastal waters receiving mixed inputs of human sewage, animal waste, and agricultural runoff provide exactly those conditions, bringing diverse bacterial populations into sustained contact while antimicrobial residues, even at subinhibitory concentrations, favor the maintenance of resistance plasmids. In this sense, the oyster supply chain functions not merely as a conduit for resistant bacteria but as a potential arena for genetic exchange, where resistance determinants circulating in the environment can recombine and redistribute among bacterial hosts before reaching consumers.

The regulatory context highlighted in the study reveals a structural gap that extends well beyond Brazil. The major shellfish-producing nations, including the United States through its National Shellfish Sanitation Program, the European Union through Regulation No 853/2004, China through its national food safety standards, and Australia through its Shellfish Quality Assurance Program, all anchor their monitoring frameworks on Escherichia coli or fecal coliform counts. These indicators are effective at signaling fecal contamination and have demonstrably reduced the burden of classic shellfish-associated illnesses. However, they were never designed to detect antimicrobial resistance. A water sample can meet the regulatory threshold for E. coli concentration while still harboring a subpopulation of resistant strains, and current classification schemes provide no mechanism to flag that risk. The Brazilian regulation, Portaria SDA/MAPA No. 884 of 2023, follows the same indicator-based logic. The consequence is that oysters harvested from waters deemed suitable for cultivation can nonetheless carry WHO critical-priority pathogens bearing clinically significant resistance genes, a scenario the Florianópolis data appear to confirm directly.

Against this backdrop, the finding that depuration reduced both resistant bacteria and the prevalence of resistance genes in oysters carries substantial practical weight. Depuration exploits the natural filtration and clearance physiology of bivalves by holding them in tanks of clean, treated, and monitored water, during which they gradually expel accumulated microorganisms. The process is already mandated or recommended in several regulatory systems for harvesting areas with moderate contamination, but its effectiveness against antimicrobial-resistant organisms specifically had been less well characterized. The study’s results suggest that depuration does not merely reduce total bacterial load but preferentially diminishes the resistant fraction and the resistance genes they carry, which is a more meaningful food safety outcome from an antimicrobial resistance perspective. This positions depuration as one of the few practical, commercially scalable interventions currently available that addresses the resistance dimension of shellfish safety rather than only the conventional microbiological indicators.

Several caveats and avenues for further work naturally follow from these findings. Depuration operates on a defined timescale, and the persistence of certain bacterial strains or genes beyond typical depuration periods remains an open question, as does the possibility that some organisms internalize in tissues in ways that resist clearance. The relationship between seawater contamination levels and resistance levels in marketed oysters, which the study observed at sites with higher environmental ARB burden, points toward water quality management as the upstream lever with the greatest potential impact. Improving sewage treatment in coastal watersheds, controlling agricultural and urban runoff, and monitoring resistance genes directly in aquaculture waters would complement depuration rather than replace it. From a One Health perspective, the study illustrates how human health outcomes at the seafood counter are connected to environmental conditions in the bay, to wastewater infrastructure on shore, and to the microbial ecology of coastal ecosystems, and it demonstrates that genomic surveillance along the supply chain can make those connections visible in actionable detail.

Subject of Research: Antimicrobial-resistant bacteria in the oyster supply chain and the effect of depuration

Article Title: Microbiological and genomic surveillance of WHO critical priority pathogens along the oyster supply chain: water quality as a driver of persistence and depuration as a mitigating strategy in a One Health context

Article References: Rocha, G., Ribas, M. R., de Assunção, I. B. F., Dal Pizzol, J. L., Wolleck, V. F., de Jesus, J. R., da Silva, G. S., Palmeiro, J. K., & Sincero, T. C. M. (2026). Microbiological and genomic surveillance of WHO critical priority pathogens along the oyster supply chain: water quality as a driver of persistence and depuration as a mitigating strategy in a One Health context. Frontiers in Bacteriology, 5, Article 1876999. https://doi.org/10.3389/fbrio.2026.1876999

Image Credits: AI Generated

DOI: 10.3389/fbrio.2026.1876999

Keywords: antimicrobial resistance, oysters, depuration, water quality, Escherichia coli, Klebsiella pneumoniae, ESBL, whole genome sequencing, One Health, food safety, plasmids, WHO priority pathogens

The analysis, covering publications from 2000 to 2025, drew on the Scopus database and followed a PRISMA-adapted screening workflow to construct a final analytical corpus of 1,746 articles and reviews spanning 432 journals and involving 11,277 unique authors. The field has expanded at a compound annual growth rate of 17.10%, accumulating 42,075 citations with an average of 24.10 citations per document. Growth accelerated sharply after 2018: annual output rose from 84 publications in 2018 to 259 in 2025, a trajectory the study attributes to increasing prioritization of antimicrobial resistance on the global research agenda and a post-pandemic surge in translational diagnostic research.

To frame the analysis, the study anchored itself in the World Health Organization’s bacterial priority pathogen lists. The WHO’s 2017 framework classified resistant bacteria into critical, high, and medium priority categories, and its 2024 update expanded the list to 24 pathogens across 15 bacterial families using multicriteria decision analysis that weighed mortality, incidence, resistance trends, transmissibility, preventability, treatability, and the state of the drug development pipeline. The critical tier now includes carbapenem-resistant Acinetobacter baumannii, carbapenem-resistant and third-generation cephalosporin-resistant Enterobacterales, and rifampicin-resistant Mycobacterium tuberculosis, while carbapenem-resistant Pseudomonas aeruginosa was moved from critical to high priority based on regional resistance trends and comparatively lower transmission capacity.

Against this backdrop, the bibliometric results reveal a field organized around distinct pathogen axes. Staphylococcus aureus dominated the corpus with 730 publications and 21,945 total citations, followed by Mycobacterium tuberculosis with 439 publications, Enterobacterales with 389, Pseudomonas aeruginosa with 309, Acinetobacter baumannii with 279, and Enterococcus faecium with 250. Growth over the past five years was strongest for Streptococcus pneumoniae at 27.79%, Pseudomonas aeruginosa at 26.35%, and Enterobacterales at 22.81%, signaling a decisive shift in research attention toward Gram-negative carbapenem resistance as the most urgent clinical frontier.

At the platform level, conventional PCR and nucleic acid amplification testing appeared in 61.51% of publications, while whole-genome sequencing featured in 55.44%, making these two technologies the twin pillars of the literature. Because platform categories were not mutually exclusive, many publications combined both approaches. Multiplex PCR stood out for impact, averaging 42.57 citations per article, reflecting the foundational role of early target-specific resistance detection. Emerging technologies, including nanopore sequencing, metagenomic sequencing, and CRISPR-based diagnostics, appeared at low frequencies but formed distinct and growing clusters, suggesting they represent innovation fronts that have not yet reached routine clinical integration.

Resistance marker analysis identified mecA/mecC, rpoB, blaNDM, katG, and vanA/vanB as the most frequently studied molecular targets. Methicillin resistance in staphylococci, epitomized by the mecA gene and its newer variant mecC, anchored the Gram-positive research tradition, while the tuberculosis markers rpoB, katG, and inhA defined a mature and specialized diagnostic axis. Carbapenemase genes, including blaKPC, blaNDM, and blaOXA-48, together with the mobile colistin resistance gene mcr and the fluoroquinolone targets gyrA and parC, showed the strongest recent growth, with gyrA and parC expanding at compound annual rates of 44.28% and 49.53% respectively over the last five years.

Thematic mapping of keyword co-occurrence networks revealed that the literature is structured around six interpretable clusters. Two emerged as mature core themes: PCR-based rapid antimicrobial resistance detection, organized around MRSA, multiplex PCR, and the mecA/mecC and vanA/vanB markers, and a whole-genome sequencing and genomic epidemiology theme spanning multiple pathogen groups. The tuberculosis resistance marker axis formed a strong but specialized mature theme, while the carbapenemase and Gram-negative resistance gene cluster, the metagenomic and nanopore clinical diagnostics cluster, and a general cross-pathogen antimicrobial resistance cluster were identified as emerging or niche research fronts.

Thematic evolution analysis across three time windows documented a clear conceptual restructuring. The early period from 2000 to 2010 centered on target-specific markers such as mecA, vancomycin resistance, and real-time PCR, reflecting an era of single-gene rapid tests. The middle period from 2011 to 2020 brought whole-genome sequencing, tuberculosis, multiplex PCR, and the Enterobacterales-carbapenemase axis to prominence. The recent period from 2021 to 2025 represents a more integrated antimicrobial resistance framework in which WGS, Staphylococcus aureus, and antibiotic resistance concepts dominate, demonstrating the field’s transition from individual marker detection to genomically integrated, translationally oriented diagnostics.

The study’s methodological rigor included a validation exercise in which 150 randomly selected records were blindly reassessed to test the rule-based text-matching system used to classify pathogens, platforms, markers, and clinical contexts. Concordance rates reached 100% for platform and resistance-marker labels, 91.3% for pathogen labels, and 86.7% for clinical-context labels, yielding an overall average agreement of 94.5%. The analysis also mapped the geography of the field: China led production with 263 publications, followed by the United States with 252, the United Kingdom with 130, and Germany with 127, though the United Kingdom and France showed higher rates of international collaboration and network centrality, revealing a divide between volume-based productivity and collaboration-intensive influence.

The findings carry important implications for clinical practice. Prior evidence shows that rapid diagnostic tests, when deployed alongside antimicrobial stewardship programs, reduce mortality in bloodstream infections compared with blood culture alone. The bibliometric structure documented here confirms that molecular diagnostics has evolved beyond answering whether a pathogen is present, into a multilayered data-generating enterprise that supports resistance prediction, monitoring of clonal spread, and clinical and public health decision-making. At the same time, the study acknowledges limitations: PCR panels and WGS report genetic content rather than physiological state, meaning phenomena such as bacterial persistence and tolerance fall largely outside the field’s marker-centered vocabulary, and future work integrating phenotypic, genomic, and virulence-layer data will be essential to close the gap between resistance prediction and treatment outcome.

Subject of Research: Bibliometric mapping of molecular diagnostic platforms and resistance markers for WHO priority bacterial pathogens

Article Title: Molecular Diagnostics for WHO Priority Bacterial Pathogens: A Bibliometric Mapping of Diagnostic Platforms, Resistance Markers, and Antimicrobial Resistance Research Trends

Article References: Ünlü, S. (2026). Molecular Diagnostics for WHO Priority Bacterial Pathogens: A Bibliometric Mapping of Diagnostic Platforms, Resistance Markers, and Antimicrobial Resistance Research Trends. MicrobiologyOpen, 15(5), Article e70394. https://doi.org/10.1002/mbo3.70394

Image Credits: AI Generated

DOI: 10.1002/mbo3.70394

Keywords: antimicrobial resistance, molecular diagnostics, WHO priority pathogens, whole-genome sequencing, PCR, bibliometric analysis, MRSA, carbapenemase genes, Mycobacterium tuberculosis, Enterobacterales, CRISPR diagnostics, genomic epidemiology